New found alliance? LOL we knew it century ago.
At $0.37 per share, and a roughly $260 million MC today. Is this not cheap enough?
Now looking forward
Data lock by end of next week
Topline data by end of next month
By a margin, you are free to move around these goal posts some days further. Regardless, there will be a rude awakening for a lot of heads when all are done soon.
The blinded data just need to be confirmed to be equally good if not better. Then
FDA has no way but to usher in a new age of how cancers will be treated with a new generation, paradigm shift immunotherapeutic cancer vaccines spearheaded by Northwest Bio's DCvax platform.
There is a risk of course, but it is worthy of taking. Many still have the pipe dream to get in cheap when things turn out to be what expected with regard to trial data.
At this point, the usual fearmongers like dilution, financing, and the like don't work any more.